Popular Articles

The Improvement Foundation - Helping Tackle The Decline In Cervical Cancer Screening Uptake
Cervical Cancer Awareness Week 8-14 June 2009 is a key time to remind women that it is of huge importance that they attend their screening appointment when asked. The Improvement Foundation (IF) aim to help tackle the decline in screening uptake by addressing levels of complacency among clinicians and the public through their national Cervical Screening Improvement Programme.

Discovery By Toronto Researcher Points To A New Treatment Avenue For Acute Myeloid Leukemia
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
News of the day
Demonstrators Gather At Washington, D.C., CVS Pharmacy To Protest Practice Of Locking Up Condoms
Protesters gathered outside a Washington, D.C., CVS Pharmacy on Thursday to urge the pharmacy chain to end the practice of locking condoms in display cases in certain neighborhoods, WJLA News reports. The protesters contend that CVS restricts access to condoms in poor black neighborhoods, whose residents may be at higher risk for HIV, other sexually transmitted infections and unintended pregnancies (WJLA News, 6/11). The protest was a part of a nationwide effort called, "Cure CVS: Unlock the Condoms Initiative," which aims to urge CVS to keep condoms unlocked at all times (Business Wire release, 6/10). CVS said in a statement, "All CVS stores sell condoms that are unlocked and accessible" (WJLA News, 6/11).
Medical Devices

Secrets Of Scorpion Venom Revealed By Genetic Analysis

Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. Researchers writing in the open access journal BMC Genomics have carried out the first ever venom analysis in this arachnid, and discovered nine novel poison molecules, never before seen in any scorpion species. Yibao Ma worked with a team of researchers from Wuhan University, China, to study the sting of S. jendeki, a member of the family Euscorpiidae, which covers Europe, Asia, Africa, and America. He said, "Our work greatly expands the current knowledge of scorpion venoms. We found ten known types and nine novel venom peptides and proteins. These molecules provide a rich, hitherto-unexplored re for drug development as well as clues into the evolution of the scorpion venom arsenal". To humans, the sting of scorpions from the Euscorpiidae family tend to be quite mild - about as painful as a mosquito bite. S. jendeki venom has never been studied before. The researchers found that it contains ten known poisons, with markedly diverse modes of action and nine new types of venom peptide, whose biological effects are yet to be determined. The scorpion itself, however, is considered harmless - probably because it cannot deliver enough of the poison to cause any damage to a healthy human. Interestingly, neurotoxins, which are major poisons in the venom of another scorpion species that can kill humans, were not found in the S. jendeki venom. Ma concludes, "Many types of venom peptides and proteins have been obtained from diverse scorpion species. Some are widely distributed among scorpions from different families, while others, like some of those discovered in our study, appear to be restricted to particular scorpion lineages. The presence of these common and uncommon venom molecules among different lineages reflects the dynamic evolutionary process of the scorpion venom arsenal". Notes: Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenal Yibao Ma, Ruiming Zhao, Yawen He, Songryong Li, Jun Liu, Yingliang Wu, Zhijian Cao and Wenxin Li. BMC Genomics (in press) http://www.biomedcentral.com/bmcgenomics/ Contact: Graeme Baldwin BioMed Central


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):